Journal
ARABIAN JOURNAL OF CHEMISTRY
Volume 14, Issue 10, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.arabjc.2021.103386
Keywords
Therapeutic effects; Tumor treatment field; Cancer cells
Categories
Funding
- Qatar National Research Fund (QNRF) [NPRP10-120-170211]
Ask authors/readers for more resources
TTFields are an active anticancer modality that disrupt mitosis in cancerous cells using low-intensity, intermediate frequency, and alternating electric fields, leading to increased chromatid aberrations and cell death. They can be combined with metallic nanoparticles for internalization into cancer cells and effectively used with chemotherapy and radiotherapy.
Tumor treating fields (TTFields) are among clinically active anticancer modalities that utilize low-intensity, intermediate frequency (IF), and alternating electric fields (AEFs) to selectively disrupt mitosis in cancerous cells. Application of TTFields in the range of 100-900 kHz in cancer therapy and its effect on normal and cancer cells have attracted a great deal of interest in recent years. TTFields affect solid tumors by introducing increased chromatid aberrations that reduce the capacity to repair DNA damage and chromosome segregation, resulting in autophagy and subsequent cell death. In this review, we present an overview of the applications of TTFields in the treatment of cancer. We discuss several practical applications of TTField frequencies combined with metallic nanoparticles (NPs) (magnetic or nonmagnetic NPs) for internalization into cancer cells. In addition, TTFields can be combined effectively with chemotherapy and radiotherapy. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of King Saud University.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available